H. El-gabalawy, L. C. Guenther, and C. N. Bernstein, Epidemiology of immune-mediated inflammatory diseases: incidence, prevalence, natural history, and comorbidities, J. Rheumatol. Suppl, vol.85, pp.2-10, 2010.

B. Bressler, B. Haraoui, E. Keystone, and A. Sette, Optimizing use of tumor necrosis factor inhibitors in the management of immunemediated inflammatory diseases, J. Rheumatol. Suppl, vol.85, pp.40-52, 2010.

C. Gabay, C. Lamacchia, and G. Palmer, IL-1 pathways in inflammation and human diseases, Nat. Rev. Rheumatol, vol.6, pp.232-241, 2010.

M. Murakami and N. Nishimoto, The value of blocking IL-6 outside of rheumatoid arthritis: current perspective, Curr. Opin. Rheumatol, vol.23, pp.273-277, 2011.

L. Kappos, D. Bates, G. Edan, M. Eraksoy, A. Garcia-merino et al., Natalizumab treatment for multiple sclerosis: updated recommendations for patient selection and monitoring, Lancet Neurol, vol.10, pp.745-758, 2011.

B. J. Oliver, E. Kohli, and L. H. Kasper, Interferon therapy in relapsing-remitting multiple sclerosis: a systematic review and meta-analysis of the comparative trials, J. Neurol. Sci, vol.302, pp.96-105, 2011.

Y. Yazici, Rheumatoid arthritis: when should we use rituximab to treat RA?, Nat. Rev. Rheumatol, vol.7, pp.379-380, 2011.

J. A. Singh, G. A. Wells, R. Christensen, E. Ghogomu, L. Maxwell et al., Adverse effects of biologics: a network meta-analysis and Cochrane overview, Cochrane Database Syst. Rev, p.8794, 2011.

D. B. Clifford, A. De-luca, D. M. Simpson, G. Arendt, G. Giovannoni et al., Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases, Lancet Neurol, vol.9, pp.438-446, 2010.

E. O. Major, Progressive multifocal leukoencephalopathy in patients on immunomodulatory therapies, Annu. Rev. Med, vol.61, pp.35-47, 2010.

B. Schraven and U. Kalinke, CD28 superagonists: what makes the difference in humans?, Immunity, vol.28, pp.591-595, 2008.

H. T. Maecker, J. P. Mccoy, M. Amos, J. Elliott, A. Gaigalas et al., A model for harmonizing flow cytometry in clinical trials, vol.11, pp.975-978, 2010.

H. T. Maecker, J. P. Mccoy, and R. Nussenblatt, Standardizing immunophenotyping for the Human Immunology Project, Nat. Rev. Immunol, vol.12, pp.191-200, 2012.